Global Cervical Cancer Therapeutics Market 2020-2024

世界の子宮頸がん治療市場2020-2024

◆タイトル:Global Cervical Cancer Therapeutics Market 2020-2024
◆商品コード:IRTNTR41609
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2020年3月27日
◆ページ数:120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アジア、ヨーロッパ、北米、その他の地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートは子宮頸がん治療の世界市場について調査・分析し、エグゼクティブサマリー、市場環境、市場規模、ファイブフォース分析、種類別(薬剤、ワクチン)分析、顧客状況、地域別状況、市場の要因と課題、企業状況、企業分析などを含め、次の構成でお届けいたします。
・エグゼクティブサマリ
・市場環境
・市場規模
・ファイブフォース分析
・子宮頸がん治療の世界市場:種類別(薬剤、ワクチン)
・顧客状況
・地域別状況
・市場の要因・課題
・企業状況
・企業分析

Global Cervical Cancer Therapeutics Market 2020-2024
Technavio has been monitoring the global cervical cancer therapeutics market 2020-2024 and it is poised to grow by USD 1.06 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period. Our reports on global cervical cancer therapeutics market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cervical cancer. In addition, the development of t-cell immunotherapy is anticipated to boost the growth of the global cervical cancer therapeutics market 2020-2024 as well.

Market Segmentation
Technavio’s global cervical cancer therapeutics market 2020-2024 is segmented as below:
Type:
• Drugs
• Vaccines

Geographic Segmentation:
• Asia
• Europe
• North America
• ROW

Key Trends for global cervical cancer therapeutics market 2020-2024 growth
This study identifies the development of t-cell immunotherapy as the prime reasons driving the global cervical cancer therapeutics market 2020-2024 growth during the next few years.

Prominent vendors in global cervical cancer therapeutics market 2020-2024
We provide a detailed analysis of around 25 vendors operating in the global cervical cancer therapeutics market 2020-2024, including some of the vendors such as Amgen Inc., Biocon Ltd., Cipla Inc., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG and Pfizer Inc. .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/cervical-cancer-therapeutics-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【資料の目次】

•Executive Summary
o Market Overview
•Market Landscape
o Market ecosystem
o Value chain analysis
•Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
•Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
•Market Segmentation by Type
o Market segments
o Comparison by Type placement
o Drugs – Market size and forecast 2019-2024
o Vaccines – Market size and forecast 2019-2024
o Market opportunity by Type
•Customer landscape
o Overview
•Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
•Drivers, Challenges, and Trends
o Market drivers
o Volume driver – Demand led growth
o Volume driver – Supply led growth
o Volume driver – External factors
o Volume driver – Demand shift in adjacent markets
o Price driver – Inflation
o Price driver – Shift from lower to higher-priced units
o Market challenges
o Market trends
•Vendor Landscape
o Overview
o Landscape disruption
•Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Amgen Inc.
o Biocon Ltd.
o Cipla Inc.
o Dr. Reddy’s Laboratories Ltd.
o F. Hoffmann-La Roche Ltd.
o Fresenius SE & Co. KGaA
o GlaxoSmithKline Plc
o Merck & Co. Inc.
o Novartis AG
o Pfizer Inc.
•Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
•1.Key Finding 1
•2.Key Finding 2
•3.Key Finding 3
•4.Key Finding 5
•5.Key Finding 6
•6.Key Finding 7
•7.Key Finding 8
•8.Market in focus
•9.Parent market
•10.Market characteristics
•11.Product / Service portfolio of key vendors included in the market definition
•12.Market segments
•13.
•14.Global – Market size and forecast 2019 – 2024 ($ million)
•15.Global market: Year-over-year growth 2019 – 2024 (%)
•16.Five forces analysis 2019 & 2024
•17.Bargaining power of buyers
•18.Bargaining power of suppliers
•19.Threat of new entrants
•20.Threat of substitutes
•21.Threat of rivalry
•22.Market condition – Five forces 2019
•23.Type placement – Market share 2019-2024 (%)
•24.Comparison by Type placement
•25.Drugs – Market size and forecast 2019-2024 ($ million)
•26.Drugs – Year-over-year growth 2019-2024 (%)
•27.Vaccines – Market size and forecast 2019-2024 ($ million)
•28.Vaccines – Year-over-year growth 2019-2024 (%)
•29. Market opportunity by Type
•30.Customer landscape
•31.Market share by geography 2019-2024 (%)
•32.Geographic comparison
•33.North America – Market size and forecast 2019-2024 ($ million)
•34.North America – Year-over-year growth 2019-2024 (%)
•35.Europe – Market size and forecast 2019-2024 ($ million)
•36.Europe – Year-over-year growth 2019-2024 (%)
•37.Asia – Market size and forecast 2019-2024 ($ million)
•38.Asia – Year-over-year growth 2019-2024 (%)
•39.ROW – Market size and forecast 2019-2024 ($ million)
•40.ROW – Year-over-year growth 2019-2024 (%)
•41.Key leading countries
•42.Market opportunity by geography ($ million)
•43.Impact of drivers and challenges
•44.Vendor landscape
•45.Landscape disruption
•46.Industry risks
•47.Vendors covered
•48.Market positioning of vendors
•49.Amgen Inc. – Overview
•50.Amgen Inc. – Business segments
•51.Amgen Inc. – Key offerings
•52.Amgen Inc. – Key customers
•53.Amgen Inc. – Segment focus
•54.Biocon Ltd. – Overview
•55.Biocon Ltd. – Business segments
•56.Biocon Ltd. – Key offerings
•57.Biocon Ltd. – Key customers
•58.Biocon Ltd. – Segment focus
•59.Cipla Inc. – Overview
•60.Cipla Inc. – Business segments
•61.Cipla Inc. – Key offerings
•62.Cipla Inc. – Key customers
•63.Cipla Inc. – Segment focus
•64.Dr. Reddy’s Laboratories Ltd. – Overview
•65.Dr. Reddy’s Laboratories Ltd. – Business segments
•66.Dr. Reddy’s Laboratories Ltd. – Key offerings
•67.Dr. Reddy’s Laboratories Ltd. – Key customers
•68.Dr. Reddy’s Laboratories Ltd. – Segment focus
•69.F. Hoffmann-La Roche Ltd. – Overview
•70.F. Hoffmann-La Roche Ltd. – Business segments
•71.F. Hoffmann-La Roche Ltd. – Key offerings
•72.F. Hoffmann-La Roche Ltd. – Key customers
•73.F. Hoffmann-La Roche Ltd. – Segment focus
•74.Fresenius SE & Co. KGaA – Overview
•75.Fresenius SE & Co. KGaA – Business segments
•76.Fresenius SE & Co. KGaA – Key offerings
•77.Fresenius SE & Co. KGaA – Key customers
•78.Fresenius SE & Co. KGaA – Segment focus
•79.GlaxoSmithKline Plc – Overview
•80.GlaxoSmithKline Plc – Business segments
•81.GlaxoSmithKline Plc – Key offerings
•82.GlaxoSmithKline Plc – Key customers
•83.GlaxoSmithKline Plc – Segment focus
•84.Merck & Co. Inc. – Overview
•85.Merck & Co. Inc. – Product and service
•86.Merck & Co. Inc. – Key offerings
•87.Merck & Co. Inc. – Key customers
•88.Merck & Co. Inc. – Segment focus
•89.Novartis AG – Overview
•90.Novartis AG – Business segments
•91.Novartis AG – Key offerings
•92.Novartis AG – Key customers
•93.Novartis AG – Segment focus
•94.Pfizer Inc. – Overview
•95.Pfizer Inc. – Business segments
•96.Pfizer Inc. – Key offerings
•97.Pfizer Inc. – Key customers
•98.Pfizer Inc. – Segment focus
•99.Currency conversion rates for US$
•100.Research Methodology
•101.Validation techniques employed for market sizing
•102.Information sources
•103.List of abbreviations



【掲載企業】

Amgen Inc., Biocon Ltd., Cipla Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc.

★調査レポート[世界の子宮頸がん治療市場2020-2024] (Global Cervical Cancer Therapeutics Market 2020-2024 / IRTNTR41609)販売に関する免責事項
[世界の子宮頸がん治療市場2020-2024] (Global Cervical Cancer Therapeutics Market 2020-2024 / IRTNTR41609)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆